tiprankstipranks
Trending News
More News >

Gland Pharma Updates RTA Contact Details Following Rebranding

Story Highlights
  • Gland Pharma operates in the pharmaceutical industry, focusing on complex injectables.
  • The company updated its RTA contact details due to a rebranding to MUFG Intime India.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.

Protect Your Portfolio Against Market Uncertainty

Gland Pharma Ltd. ( (IN:GLAND) ) just unveiled an announcement.

Gland Pharma Limited has announced a change in the contact details of its Registrar and Share Transfer Agent (RTA) due to a rebranding from ‘Link Intime India Private Limited’ to ‘MUFG Intime India Private Limited’. This update is crucial for shareholders and stakeholders who need to interact with the RTA for queries or service requests, ensuring continued smooth operations and communication.

More about Gland Pharma Ltd.

Gland Pharma Limited operates in the pharmaceutical industry, focusing on the development, manufacturing, and marketing of complex injectables. The company is known for its wide range of products that cater to various therapeutic areas, serving both domestic and international markets.

YTD Price Performance: -18.25%

Average Trading Volume: 14,139

Current Market Cap: 238.9B INR

See more insights into GLAND stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App